These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 22064247
1. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer. Wang ZX, Xue D, Liu ZL, Lu BB, Bian HB, Pan X, Yin YM. Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247 [Abstract] [Full Text] [Related]
3. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma. Cheng MW, Wang BC, Weng ZQ, Zhu XW. Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864 [Abstract] [Full Text] [Related]
4. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH. Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094 [Abstract] [Full Text] [Related]
5. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549]. Zhou Q, Bai M, Su Y. Ai Zheng; 2005 Feb 05; 24(2):149-54. PubMed ID: 15694023 [Abstract] [Full Text] [Related]
8. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z. Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282 [Abstract] [Full Text] [Related]
10. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression. He Z, Wu J, Dang H, Lin H, Zheng H, Zhong D. Cancer Lett; 2011 Apr 28; 303(2):92-8. PubMed ID: 21330050 [Abstract] [Full Text] [Related]
11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y. Eur J Cancer; 2011 Oct 28; 47(15):2353-63. PubMed ID: 21680174 [Abstract] [Full Text] [Related]
12. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas. Jang YJ, Kim YS, Kim WH. Int J Oncol; 2006 Sep 28; 29(3):589-94. PubMed ID: 16865274 [Abstract] [Full Text] [Related]
14. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR. Gastroenterology; 2012 Mar 28; 142(3):521-530.e3. PubMed ID: 22108192 [Abstract] [Full Text] [Related]
15. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo]. Lan B, Liu BY, Cheng XH, Qu Y, Zhang XQ, Cai Q, Dai QB, Zhu ZG. Zhonghua Wai Ke Za Zhi; 2006 Jan 01; 44(1):40-4. PubMed ID: 16620646 [Abstract] [Full Text] [Related]
19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L, Wang Y, Xiao M, Lin Y, Yu L. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 01; 110(4):484-91. PubMed ID: 20868995 [Abstract] [Full Text] [Related]
20. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rübsamen-Waigmann H, Strebhardt K. Oncogene; 1997 Feb 06; 14(5):543-9. PubMed ID: 9053852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]